Table 4.
Maternal erythrocyte DHA concentration before and after supplementation.
| Group | Baseline (% of total fatty acids) Mean ± SD | Baseline 95% CI | 6 Months (% of total fatty acids) Mean ± SD | 6 Months 95% CI | Mean difference | % Change | p-value |
|---|---|---|---|---|---|---|---|
| Urban control | 2.1 ± 0.3 | 1.93–2.27 | 2.2 ± 0.2 | 2.09–2.31 | +0.1 | +4.8 | 0.312 |
| Urban supplemented | 2.2 ± 0.2 | 2.09–2.31 | 4.8 ± 0.4 | 4.58–5.02 | +2.6 | +118.2 | <0.001*** |
| Rural control | 1.9 ± 0.2 | 1.79–2.01 | 2.0 ± 0.3 | 1.83–2.17 | +0.1 | +5.3 | 0.285 |
| Rural supplemented | 2.0 ± 0.3 | 1.83–2.17 | 4.2 ± 0.3 | 4.03–4.37 | +2.2 | +110.0 | <0.001*** |
Values are expressed as mean ± standard deviation (SD) (n = 15 mothers per group). Erythrocyte DHA concentration is expressed as percentage of total fatty acids. Baseline measurements were obtained at 1 month postpartum and post-intervention measurements at 6 months postpartum. Ninety-five percent confidence intervals (95% CI) were calculated around the mean values. Within-group comparisons were performed using paired Student’s t-tests. Statistical significance was established at p < 0.05. ***p < 0.001. DHA, Docosahexaenoic Acid; CI, Confidence Interval.